Previous 10 | Next 10 |
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the second quarter and first six months of fiscal year 2023, ended September 30, 2022. Commenting on ...
ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE BOARD OF DIRECTORS PR Newswire The New Board Members Will Bring Industry Experience to Contribute to Company Growth WOODINVILLE, Wash. , Nov. 2, 2022 /PRNewswire/ -- Anavasi Diagnostics (...
Summary A handful of past VBR picks are becoming net asset turnaround ideas on price weakness. Ultra-low price to tangible book value and EV to EBITDA readings are entering bargain territory. Steady insider buying is taking place in each name. I have purchased shares...
Cyanotech press release ( NASDAQ: CYAN ): Q1 GAAP EPS of -$0.08. Revenue of $6.72M (-25.0% Y/Y). For further details see: Cyanotech GAAP EPS of -$0.08, revenue of $6.72M
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the first quarter of fiscal year 2023, ended June 30, 2022. Commenting on the first quarter fiscal 20...
Quick review of past picks and my selection process. Explanation of how missing one big winner can dramatically alter performance totals. 4 new VBR buy signals outlined. "Volume precedes price" is an idea with some statistical backing, widely followed by traders and inve...
The initial VBR list declined slightly during the first week of trading but soundly beat the rotten Wall Street drop overall of -2%. I discuss four new ideas for momentum investors searching for short-term, heavy-volume breakouts, using proprietary sorting formulas. A second impor...
I am looking for ways to report on my quant formula sorting results in quicker fashion for readers. The Volume Reversal Report intends to highlight the past week's most interesting high-volume gainers I can find. Six names stand out to me as having above-average odds of superior g...
Cyanotech press release (NASDAQ:CYAN): FY GAAP EPS of $0.35. Revenue of $35.97M (+11.2% Y/Y). For further details see: Cyanotech GAAP EPS of $0.35, revenue of $35.97M
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the fourth quarter and fiscal year 2022, ended March 31, 2022. Commenting on the fiscal year results ...
News, Short Squeeze, Breakout and More Instantly...
Cyanotech Corporation Company Name:
CYAN Stock Symbol:
NASDAQ Market:
Cyanotech Corporation Website:
The new gummy offers an industry-leading 12mg of Hawaiian Astaxanthin ® per serving – 6000 times the antioxidant power of Vitamin C – with science-backed, multifunctional benefits and a 40-year legacy of farm-direct transparency and traceability. Nutrex-Hawaii...
The Dow Jones index closed lower by around 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern a...
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the third quarter and first nine months of fiscal year 2024, ended December 31, 2023. Commenting on the third...